Quinomycin G (1), a new analogue of echinomycin, together with a new cyclic dipeptide, cyclo-(l-Pro-4-OH-l-Leu) (2), as well as three known antibiotic compounds tirandamycin A (3), tirandamycin B (4) and staurosporine (5), were isolated from Streptomyces sp. LS298 obtained from a marine sponge Gelliodes carnosa. The planar and absolute configurations of compounds 1 and 2 were established by MS, NMR spectral data analysis and Marfey’s method. Furthermore, the differences in NMR data of keto-enol tautomers in tirandamycins were discussed for the first time. Antibacterial and anti-tumor activities of compound 1 were measured against 15 drug-sensitive/resistant strains and 12 tumor cell lines. Compound 1 exhibited moderate antibacterial activities against Staphylococcuse pidermidis, S. aureus, Enterococcus faecium, and E. faecalis with the minimum inhibitory concentration (MIC) values ranged from 16 to 64 μg/mL. Moreover, it displayed remarkable anti-tumor activities; the highest activity was observed against the Jurkat cell line (human T-cell leukemia) with an IC50 value of 0.414 μM.
从海洋海绵 Gelliodes carnosa 中获得的链霉菌 LS298 中分离出了
棘霉素的新类似物喹诺霉素 G (1)、一种新的环状二肽环-(l-Pro-4-OH-l-Leu) (2),以及三种已知的抗生素化合物 tirandamycin A (3)、tirandamycin B (4) 和 staurosporine (5)。通过质谱、核磁共振光谱数据分析和马
菲法,确定了化合物 1 和 2 的平面构型和绝对构型。此外,还首次讨论了替兰达霉素酮烯醇同分异构体核磁共振数据的差异。化合物 1 针对 15 种药物敏感/耐药菌株和 12 种肿瘤
细胞系进行了抗菌和抗肿瘤活性测定。化合物 1 对表皮葡萄球菌、
金黄色葡萄球菌、粪肠球菌和粪大肠杆菌具有中等程度的抗菌活性,最低抑菌浓度 (MIC) 值介于 16 至 64 μg/mL 之间。此外,它还显示出显著的抗肿瘤活性;对 Jurkat
细胞系(人类 T 细胞白血病)的活性最高,IC50 值为 0.414 μM。